Advertisement

Picture EBD Group Biotech Showcase 2019 BTS San Francisco Partnering 600x60px
Document › Details

PerkinElmer, Inc.. (12/27/17). "Press Release: PerkinElmer to Present at J.P. Morgan 36th Annual Healthcare Conference". Waltham, MA.

Region Region San Francisco, CA
  Country United States (USA)
Organisations Organisation PerkinElmer Inc. (NYSE: PKI)
  Group PerkinElmer (Group)
  Organisation 2 J.P. Morgan Securities LLC
  Group JPMorgan Chase (Group)
Products Product J.P. Morgan 36th Annual Healthcare Conference 2018 San Francisco
  Product 2 analytical instrument
Index term Index term PerkinElmer–JPMorgan Chase: investor conference, 201801 supply service PerkinElmer presents at JP Morgan Healthcare Conference 2018
Persons Person Friel, Robert F. (PerkinElmer 200802– CEO before COO before President Life+Analytical joined 1999 as CFO)
  Person 2 Thomas, Tommy J. (PerkinElmer 201501 Investor Relations Manager)
     


PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that the Company will present at the J.P. Morgan 36th Annual Healthcare Conference on Wednesday, January 10, 2018 at 8:00 am PT at the Westin St. Francis Hotel in San Francisco.

Robert F. Friel, PerkinElmer's chairman and chief executive officer, will provide an overview of the Company and its strategic priorities.

A live audio webcast of the presentation will also be available on the Investors section of the Company's website at www.perkinelmer.com. A replay of the presentation will be posted on the PerkinElmer website after the event and will be available for two weeks following.


About PerkinElmer

PerkinElmer, Inc. is a global leader committed to innovating for a healthier world. Our dedicated team of 11,400 employees worldwide is passionate about providing customers with an unmatched experience as they help solve critical issues especially impacting the diagnostics, discovery and analytical solutions markets. Our innovative detection, imaging, informatics and service capabilities, combined with deep market knowledge and expertise, help customers gain earlier and more accurate insights to improve lives and the world around us. The Company reported revenue of approximately $2.1 billion in 2016, serves customers in more than 150 countries, and is a component of the S&P 500 Index. Additional information is available through 1-877-PKI-NYSE, or at www.perkinelmer.com.


PerkinElmer, Inc.

Investor Relations:
Tommy J. Thomas, 781-663-5889
tommy.thomas@perkinelmer.com

or

Media:
Brian Willinsky, 781-663-5728
brian.willinsky@perkinelmer.com

   
Record changed: 2018-01-09

Advertisement

Picture EBD Group Biotech Showcase 2019 BTS San Francisco January DIC 600x60px

More documents for PerkinElmer (Group)


To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

Advertisement

Picture EBD Group Biotech Showcase 2019 BTS San Francisco Investors 600x60px




» top